Discover how and why an allergic reaction develops…
Current statistics indicate that over 150 million people in Europe have allergies, and more than 230 million people worldwide are affected by asthma. Furthermore, in the workplace, the issue of chemical allergies is very difficult to deal with.
This 1 hour and 45 -minute live webinar led by expert toxicologist Laura Robinson, covers the definition of ‘allergy’, how allergies occur, the methods which can be used to assess for such effects, and what to do if chemical sensitisers are being used in the workplace.
With this knowledge you will be able to determine whether the reported effects are adverse; which would have consequences for classification and labelling and risk assessment work. It will also cover current classification and labelling criteria under the CLP (classification, labelling and packaging) Regulation (CE) 1272/2008 and the GHS (Globally Harmonised System of Classification and Labelling of Chemicals) for skin and respiratory sensitisers.
Fee: 249 euros/ delegate
What you will learn
The following topics will be discussed over the course of this webinar:
Part I – Introduction to the immune system and allergies
- Definition of allergy, hypersensitivity, atopy,
- The difference between innate and the acquired immune response
- Categories of immunological response
- The role of antibodies in the development of an immune response
Part II – allergic contact dermatitis
- The anatomy of the skin in relation to the development of an allergic response
- The cells of the immune system involved in the development of allergic contact dermatitis
- Factors which influence the development of allergic contact dermatitis
- How allergic contact dermatitis differs from irritant contact dermatitis
- Current testing strategies for the assessment of skin sensitisers ( in vivo, and in vitro/ in chemico methods as part of the adverse outcome pathway
Part III – Respiratory allergy
- What is meant by respiratory allergy and respiratory sensitisers
- How respiratory allergy differs to allergic contact dermatitis
- The difference between occupational asthma (allergic and non-allergic) and work aggravated asthma
- Current testing strategies for the assessment of respiratory sensitisers
Part IIII-Classification and labelling under EU CLP/GHS
- Criteria for assessment of respiratory and skin sensitisers
Part IV – The consequences of developing an allergy in the workplace
- Important considerations in relation to control measures in the workplace
Who should attend?
- Technical/scientific staff who work in a regulatory department
- Authors of safety data sheets (SDS) and/or extended safety data sheets (eSDS)
- Occupational hygienists
- HSE staff who need to understand the impact of working with skin and respiratory sensitisers in the workplace
- Dangerous Goods safety advisors
- Sales/Marketing teams looking to develop their knowledge of chemical allergies (skin and respiratory sensitisers)
- Occupational health advisors
- Anyone looking to develop their understanding of Chemical allergies
About the webinar
A unique feature of this training webinar is that you are encouraged to ‘raise your hand’ and put questions forward throughout the training – just as you would in a classroom environment. Fee: 249 euros/ delegate
What is included
- Invitation to attend the live 1 hour and 45-minute training webinar
- A copy of the slides
- A course manual which covers the material covered during the session
- A free 20-minute follow-up session with the trainer
Please note, an introductory/basic toxicology background would be of use for this particular webinar.
What others say about these webinars
“Many thanks to you for this very good training session (Ecotoxicology & CLP Webinar). The training materials are very good and well presented.” E.C. Scientific & Technical Affairs Manager, Belgium.
“Thank you so much for the Toxicology Webinar. I found it highly informative and relevant. Laura paced the content very well, she was clear, interesting, and demonstrated not only the facts but how they are then applied in practice. I enjoyed it very much”. Dr.Sue Elton M.R.C.G.